What are the outcomes of surgical treatment for moyamoya syndrome in patients with sickle cell anemia?
The outcome of surgical treatment for moyamoya syndrome in patients with sickle cell anemia was studied in a 2008 paper by Hankinson et al. They found that encephaloduroarteriosynangiosis (EDAS) procedure resulted in improved outcomes for patients with sickle cell anemia and moyamoya syndrome. The study reported that the majority of patients had improved neurological function and improved brain imaging findings. However, some patients experienced complications such as intracranial haemorrhage and seizures. Overall, the authors concluded that EDAS procedure is a safe and effective treatment for patients with moyamoya syndrome and sickle cell anemia. 